Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
Christopher R. Brown(Alnylam Pharmaceuticals (United States)), Vasant Jadhav(Alnylam Pharmaceuticals (United States)), June Qin(Alnylam Pharmaceuticals (United States)), Anil V. Nair(Harvard University), Mikyung Yu(Alnylam Pharmaceuticals (United States)), Scott Lentini(Alnylam Pharmaceuticals (United States)), Timothy Racie(Alnylam Pharmaceuticals (United States)), Mark K. Schlegel(Alnylam Pharmaceuticals (United States)), Muthusamy Jayaraman(Forma Therapeutics (United States)), Rubina Parmar(Alnylam Pharmaceuticals (United States)), Ryan J. Malone(Urology of Indiana), Martin A. Maier(Alnylam Pharmaceuticals (United States)), Shigeo Matsuda(Alnylam Pharmaceuticals (United States)), Swati Gupta(Alnylam Pharmaceuticals (United States)), Christopher S. Theile(Alnylam Pharmaceuticals (United States)), Ivan Zlatev(Alnylam Pharmaceuticals (United States)), Varun Goel(Alnylam Pharmaceuticals (United States)), Muthiah Manoharan(Alnylam Pharmaceuticals (United States)), Karyn Schmidt(Alnylam Pharmaceuticals (United States)), Dennis Brown(Massachusetts General Hospital), Azar Shahraz(Alnylam Pharmaceuticals (United States)), Svetlana Shulga‐Morskaya(Alnylam Pharmaceuticals (United States)), He Guo(Alnylam Pharmaceuticals (United States)), Jayaprakash K. Nair(Alnylam Pharmaceuticals (United States))
Cited by 280
Related Papers
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
|Molecular Therapy|2010|1.2k
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
|Nature Biotechnology|2008|1.2k